Searched for
SUN PHARMA NET PROFIT GROWTH
Indian IT firms likely to report muted Q1 growth amid AI spending, macro uncertaintyIndia's Information Technology (IT) companies are expected to report another quarter of subdued earnings growth despite seasonal strength, ...- US, West Asia drag India's pharma exports growthIndian pharmaceutical exports to the US, its largest market, saw a dip in early fiscal months, alongside a slight decline in shipments to W...
- Sun Pharma secures relief in 'Pantocid' trademark disputeDelhi High Court has halted Ahmedabad-based Finecure Pharmaceuticals from producing and selling drugs with names similar to Sun Pharma's 'P...
- Dabur, Godrej say demand holds firm despite cost pressuresIndian consumer goods giants Dabur and Godrej Consumer Products reported resilient demand in early fiscal 2027, defying geopolitical worrie...
- Kusumgar IPO price band fixed at Rs 398–419; Rs 650-crore issue opens July 8, GMP at 33%Kusumgar has set its IPO price band at Rs 398–419 for a Rs 650-crore offer for sale, opening July 8. The issue has a grey market premium of...
- Swara Baby files DRHP with Sebi for Rs 1,000 crore IPOSwara Baby has filed its DRHP with Sebi for a Rs 1,000 crore IPO, comprising a Rs 500 crore fresh issue and Rs 500 crore OFS. The hygiene p...
- From deep correction to fresh peaks: 10 stocks soar from 52-week lows to new highs in just three monthsSeveral large-cap Indian companies have seen their stock prices surge from 52-week lows to highs within just three months. This impressive ...
- Advit Jewels share price slides 5% after strong 37% market debut. Should you buy, sell or hold?Advit Jewels shares made a strong stock market debut, listing at a 37% premium to the IPO price before trimming gains. While analysts remai...
- KPIT Tech shares crash 17% as company expects Q1 revenue decline, sharp hit to marginsKPIT Technologies shares plunged 17% after the company warned of a revenue drop in Q1 FY27, citing unexpected actions from European automak...
- Waterways Leisure shares slip on debut, list at 16% discount to IPO priceAhead of the listing, the IPO is commanding a grey market premium (GMP) of -Rs 51, implying a 6.31% discount to the upper price band of Rs ...
- Trump filing shows he took in about $1.2 billion from crypto businesses last yearPresident Trump's crypto ventures reportedly raked in nearly $1.2 billion last year, eclipsing his property empire. While investors faced l...
- 5 Zodiac Signs Will Receive Unexpected Money In July 2026: Major Financial Breakthroughs, Surprise Cash & Powerful Cosmic Blessings AwaitUnexpected money rarely arrives the way we imagine. It's not always a lottery win or a surprise inheritance, more often, it shows up as an ...
- Hindustan Copper pins Navratna ambitions on 50,000 TPA Jhagadia ProjectHindustan Copper's Jhagadia project in Gujarat, a 50,000-tonne secondary copper smelter, is poised to significantly boost the company's rev...
- Sensex rises over 200 points, Nifty above 24,000; Maruti Suzuki shares jump 3%Indian stock markets rebounded on Tuesday, with both Sensex and Nifty climbing approximately 0.4% after a dip in the previous session. The ...
- Quote of the Day by Sun Tzu: "Place your army on death ground, and it will survive; plunge it into desperate straits, and it will..." — Ultimate life lessons on winning the war: The Art of War reveals why your greatest victories begin when retreat is impossibleQuote of the Day by Sun Tzu explores one of history's most enduring lessons on courage, commitment, and human psychology. In Chapter 11 of ...
- Honasa Consumer to acquire majority stake in Fluence Pharma at Rs 135-crore valuationHonasa Consumer has secured a majority stake in Mumbai's hair therapy brand Fluence Pharma for Rs 135 crore. This move marks the company's ...
- Defence valuations 'obnoxious'; private banks look strong: Sandip Sabharwal's full market playbookInvestor Sandip Sabharwal cautions that while the defence rally is real, many stock prices have outpaced reality. He favors Bharat Electron...
- Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal ManchandaIndia's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...
- Stocks in news: Sun Pharma, Tech Mahindra, Tata Motors, Voltas, ONGCIndian markets saw a dip on Friday, with IT stocks leading the decline. Analysts suggest profit-taking occurred near the 24,150 mark. Despi...
- Sun Pharma adds Innovcare to its fold in Rs 271.2 crore all-cash transactionIndia's largest drugmaker, Sun Pharma, is set to acquire Mumbai-based Innovcare Lifesciences for approximately $28.7 million in an all-cash...
Load More
